In a significant medical milestone for Iraq, Vision RT announced the clinical implementation of its advanced DoseRT radiotherapy technology at two Iraqi medical institutions, marking its first use outside Europe and the United States.

The technology has been introduced at the Warith International Cancer Treatment Center in Karbala and Al-Thaqalayn Cancer Treatment Hospital in Basra, where medical and engineering teams successfully completed its installation and began using it to treat patients.

DoseRT enables real-time monitoring of radiation doses during treatment, helping improve delivery accuracy, patient safety, and the overall quality of cancer care.

In a statement on its official platforms, Vision RT described the implementation as an important step in the technology's global expansion, praising the expertise and cooperation of the Iraqi medical and technical teams. The company also acknowledged the support of Dr. Haider Al-Abadi, CEO of the hospital group, and the efforts of staff at both institutions.

This achievement marks another step toward advancing Iraq's cancer treatment services, introducing cutting-edge medical technologies, strengthening national expertise, and providing patients with access to advanced care within the country.